NDUFAF1
protein-codingNADH:ubiquinone oxidoreductase complex assembly factor 1, the group of Mitochondrial complex I assembly complex|Mitochondrial respiratory chain complex assembly factors
Gene summary
This gene encodes a complex I assembly factor protein. Complex I (NADH-ubiquinone oxidoreductase) catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q) in the first step of the mitochondrial respiratory chain, resulting in the translocation of protons across the inner mitochondrial membrane. The encoded protein is required for assembly of complex I, and mutations in this gene are a cause of mitochondrial complex I deficiency. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 19. [provided by RefSeq, Dec 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~22.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100133
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *NDUFAF1* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of February 17, 2022. The *NDUFAF1* gene encodes the NADH:ubiquinone oxidoreductase (complex I) assembly factor I. Defects of this protein lead to complex I deficiency. The *NDUFAF1* gene was first reported in relation to autosomal recessive primary mitochondrial disease in 2007 (PMID: 17557076). While various names have been given to the constellation of features seen in those with *NDUFAF1*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *NDUFAF1* phenotype has been lumped into one disease entity according to per the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included four variants in two cases from two publications (PMIDs: 17557076, 21931170). No segregation data were available. Loss of function resulting in a complex I assembly defect is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, functional alterations in patient and non-patient cells, and animal models (PMIDs: 27509854, 27626371, 18940309, 22387847, 23226344). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on February 17, 2022 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0032617
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032617
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032617
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Medical treatment (eg, riboflavin, ubiquinol) may be beneficial; Individuals may have cardiac involvement
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NDUFAF1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_016013.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 25 | 2 | 29 | ||
| missense | 1 | 2 | 108 | 8 | 2 | 121 |
| nonsense | 2 | 2 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | 2 | 3 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 3 | 2 | 117 | 33 | 4 | 159 |
Highest pathogenic variant AF is 0.000029740551
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_057097.2 | 4 | MANE Select | |
| Ensembl | ENSP00000260361.4 | 4 | MANE Select | |
| RefSeq | NP_001424415.1 | 4 | Standard | |
| RefSeq | NP_001424416.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thermogenesis - Homo sapiens (human)
- Respiratory electron transport
- The citric acid (TCA) cycle and respiratory electron transport
- Metabolism
- Complex I biogenesis
Biological Process
- mitochondrial electron transport, NADH to ubiquinone
- mitochondrial respiratory chain complex I assembly
- protein-containing complex assembly
Molecular Function
- protein binding
- unfolded protein binding
Cellular Component
- mitochondrion
- mitochondrial inner membrane
- mitochondrial respiratory chain complex I
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000260361
- Coding exons
- 4
- Length
- 15167
- Individuals with no LoFs
- 125715
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 33
- Defined
- 125748
- p
- 0.000131
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.442 | 198 | 181 | 1.09 | 0.0000102 | 2170 |
| Missense (PolyPhen) | 65 | 62.583 | 1.0386 | 745 | ||
| Synonymous | 1.04 | 55 | 65.7 | 0.837 | 0.00000371 | 618 |
| Loss of Function | 1.82 | 6 | 13.1 | 0.458 | 7.11e-7 | 153 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000088 | 0.000088 | rare |
| South Asian | 0.00042 | 0.00042 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Chaperone protein involved in the assembly of the mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). {ECO:0000250}.;
Intolerance Scores
- LoFtool
- 0.699
- RVIS EVS
- 0.58
- RVIS percentile EVS
- 82.17
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.626
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |